UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

Critical care medicine, 2009-05, Vol.37 (5), p.1612-1618

2009

Volltextzugriff (PDF)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Volltextzugriff (PDF)

Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia

Intensive care medicine, 2006-11, Vol.32 (11), p.1766-1772

2006

Volltextzugriff (PDF)

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Clinical infectious diseases, 2022-01, Vol.74 (2), p.364-366

2022

Volltextzugriff (PDF)

Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units

Journal of antimicrobial chemotherapy, 2012-06, Vol.67 (6), p.1525-1536

2012

Volltextzugriff (PDF)

Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial

Intensive care medicine, 2004-05, Vol.30 (5), p.837-843

2004

Volltextzugriff (PDF)

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results

Critical care medicine, 2003-09, Vol.31 (9), p.2291-2301

2003

Volltextzugriff (PDF)

Respiratory tract infections: at-risk patients, who are they?: Implications for their management with levofloxacin

International journal of antimicrobial agents, 2006-09, Vol.28, p.S113-S114

Sollet, Jean-Pierre

2006

Volltextzugriff (PDF)

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial

Critical care medicine, 1998-12, Vol.26 (12), p.1963-1971

1998

Volltextzugriff (PDF)

Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries

The Journal of infectious diseases, 2024-06, Vol.229 (6), p.1679-1687

2024

Volltextzugriff (PDF)

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 Suppl 3 (Supplement 3), p.iii19-iii32

2011

Volltextzugriff (PDF)

Selecting patients with severe sepsis for drotrecogin alfa (activated) therapy

The American journal of surgery, 2002-12, Vol.184 (6), p.S11-S18

2002

Volltextzugriff (PDF)

Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period

Genome medicine, 2021-05, Vol.13 (1), p.77-77, Article 77

2021

Volltextzugriff (PDF)

Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts

Critical care (London, England), 2021-02, Vol.25 (1), p.87-87, Article 87

2021

Volltextzugriff (PDF)

Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia

Journal of Clinical Microbiology, 2011-03, Vol.49 (3), p.777-783

2011

Volltextzugriff (PDF)

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

Annals of internal medicine, 2000-04, Vol.132 (8), p.621

2000

Volltextzugriff (PDF)

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Clinical infectious diseases, 2022-01, Vol.74 (2), p.364-366

2022

Volltextzugriff (PDF)

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1035-O1041

2014

Volltextzugriff (PDF)

Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity

The Pediatric infectious disease journal, 2014-08, Vol.33 (8), p.872-879

2014

Volltextzugriff (PDF)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Volltextzugriff (PDF)

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome

Epidemiology and infection, 2014-12, Vol.142 (12), p.2672-2683

2014

Volltextzugriff (PDF)

Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients

International journal of medical microbiology, 2013-12, Vol.303 (8), p.529-532

2013

Volltextzugriff (PDF)

INDEPTH DATABASE OF SEVERE SEPSIS PATIENTS SHOWS FEWER CARDIAC EVENTS IN DROTRECOGIN ALFA (ACTIVATED) PATIENTS VS PLACEBO PATIENTS

Chest, 2005-10, Vol.128 (4), p.378S-378S

2005

Volltextzugriff (PDF)

Iatrogenic complications in adult intensive care units: A prospective two-center study

Critical care medicine, 1993-01, Vol.21 (1), p.40-51

1993

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)
Tagungsberichte
(1)

Sprache

Englisch
(28)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(21)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Middle Aged
(14)
Female
(12)
Male
(12)
Adult
(11)
Aged
(11)
Infectious Diseases
(11)
Microbiology
(10)
General & Internal Medicine
(9)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(8)
Bacteremia - Microbiology
(8)
Critical Care Medicine
(8)
Escherichia Coli
(8)
Intensive Care Medicine
(8)
Aged, 80 And Over
(7)
Escherichia Coli Infections - Microbiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units

Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results

Respiratory tract infections: at-risk patients, who are they?: Implications for their management with levofloxacin

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial

Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Selecting patients with severe sepsis for drotrecogin alfa (activated) therapy

Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period

Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts

Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome

Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients

INDEPTH DATABASE OF SEVERE SEPSIS PATIENTS SHOWS FEWER CARDIAC EVENTS IN DROTRECOGIN ALFA (ACTIVATED) PATIENTS VS PLACEBO PATIENTS

Iatrogenic complications in adult intensive care units: A prospective two-center study

Suchergebnisse filtern